Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-01-18

FDA Approved: GABAPENTIN — Original Application (Advagen Pharma Ltd)

View source ↗

Summary

FDA approved Advagen Pharma Ltd's gabapentin in an Original Application, granting a generic version of gabapentin (ANDA 216492).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Gabapentin (Gabapentin)

Snippet

ORIG AP for GABAPENTIN (GABAPENTIN)